Leonid Gaidukov

4.2k citations

24 papers · 3.1k indexed · 2 hit papers · h-index 22

Co-authors: Dan S. Tawfik Amir Aharoni Olga Khersonsky Amram Mor Cintia Roodveldt Israel Silman Lilly Toker Mira Rosenblat
Topics: Paraoxonase enzyme and polymorphisms (10 papers)Antimicrobial Peptides and Activities (7 papers)Biochemical and Structural Characterization (5 papers)
Cited by: Clinical Biochemistry Microbiology Biochemistry
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Journal of Biological Chemistry
Partner nations: Israel United States Hong Kong

In The Last Decade

Leonid Gaidukov

24 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The 'evolvability' of promiscuous protein functions

2004 660 citations Amir Aharoni, Leonid Gaidukov et al. Nature Genetics profile →
Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes

2004 501 citations Michal Harel, Amir Aharoni et al. Nature Structural & Molecular Biology profile →

Peers

Countries citing papers authored by Leonid Gaidukov

Since Specialization

Citations

This map shows the geographic impact of Leonid Gaidukov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonid Gaidukov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonid Gaidukov more than expected).

Fields of papers citing papers by Leonid Gaidukov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonid Gaidukov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonid Gaidukov. The network helps show where Leonid Gaidukov may publish in the future.

Co-authorship network of co-authors of Leonid Gaidukov

This figure shows the co-authorship network connecting the top 25 collaborators of Leonid Gaidukov. A scholar is included among the top collaborators of Leonid Gaidukov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonid Gaidukov. Leonid Gaidukov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A synthetic transcription platform for programmable gene expression in mammalian cells 2022 ·Nature Communications ·Chien‐Wen Chen,Leonid Gaidukov,Yong Lai,Ming-Ru Wu,Jicong Cao,(unknown),Gigi C.G. Choi,(unknown),Ying‐Chou Chen,Liliana Wróblewska,Manolis Kellis,Lin Zhang,Ron Weiss,Timothy K. Lu	19
2	Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12 2020 ·Molecular Cancer Therapeutics ·Nuruddeen D. Lewis,Chang Ling Sia,Katherine Kirwin,Sonya Haupt,(unknown),Tong Zi,(unknown),Kevin Dooley,Su Chul Jang,Bryan D. Choi,Adam T. Boutin,(unknown),Christine McCoy,Jorge Sanchez-Salazar,Michael Doherty,Leonid Gaidukov,Scott Estes,Kyriakos D. Economides,Douglas E. Williams,Sriram Sathyanarayanan	79
3	Small-molecule control of antibody N-glycosylation in engineered mammalian cells 2019 ·Nature Chemical Biology ·Michelle Chang,Leonid Gaidukov,Giyoung Jung,Wen Allen Tseng,John J. Scarcelli,(unknown),Jeffrey Marshall,(unknown),Paul Sakorafas,(unknown),(unknown),(unknown),Sepideh Dolatshahi,Madhuresh Sumit,Bhanu Chandra Mulukutla,Douglas A. Lauffenburger,Bruno Figueroa,(unknown),Timothy K. Lu,Ron Weiss	55
4	A multi-landing pad DNA integration platform for mammalian cell engineering 2018 ·Nucleic Acids Research ·Leonid Gaidukov,Liliana Wróblewska,Brian Teague,(unknown),Xin Zhang,Yan Liu,(unknown),(unknown),Wen Allen Tseng,(unknown),Jishnu Das,(unknown),(unknown),(unknown),Timothy K. Lu,Lin Zhang,Ron Weiss	115
5	Glycine Dimerization Motif in the N-terminal Transmembrane Domain of the High Density Lipoprotein Receptor SR-BI Required for Normal Receptor Oligomerization and Lipid Transport 2011 ·Journal of Biological Chemistry ·Leonid Gaidukov,Andrew R. Nager,Shangzhe Xu,Marsha Penman,Monty Krieger	52
6	In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes 2009 ·PubMed ·Leonid Gaidukov,(unknown),Shiri Yacobson,(unknown),(unknown),Rinat Tabakman,Dan S. Tawfik,Etgar Levy‐Nissenbaum	35
7	ApoE Induces Serum Paraoxonase PON1 Activity and Stability Similar to ApoA-I 2009 ·Biochemistry ·Leonid Gaidukov,(unknown),Shiri Yacobson,Mira Rosenblat,Michael Aviram,Dan S. Tawfik	45
8	The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity 2007 ·Journal of Lipid Research ·Leonid Gaidukov,Dan S. Tawfik	71
9	The Catalytic Histidine Dyad of High Density Lipoprotein-associated Serum Paraoxonase-1 (PON1) Is Essential for PON1-mediated Inhibition of Low Density Lipoprotein Oxidation and Stimulation of Macrophage Cholesterol Efflux 2006 ·Journal of Biological Chemistry ·Mira Rosenblat,Leonid Gaidukov,Olga Khersonsky,Jacob Vaya,Roni Oren,Dan S. Tawfik,Michael Aviram	196
10	Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase 2006 ·FEBS Journal ·Gabriel Amitai,Leonid Gaidukov,R. Adani,(unknown),(unknown),Moshe Kushnir,(unknown),(unknown),(unknown),Olga Khersonsky,Dan S. Tawfik,Haim Meshulam	73
11	The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux 2006 ·Journal of Lipid Research ·Leonid Gaidukov,Mira Rosenblat,Michael Aviram,Dan S. Tawfik	112
12	High Affinity, Stability, and Lactonase Activity of Serum Paraoxonase PON1 Anchored on HDL with ApoA-I 2005 ·Biochemistry ·Leonid Gaidukov,Dan S. Tawfik	185
13	Effects of Acyl versus Aminoacyl Conjugation on the Properties of Antimicrobial Peptides 2005 ·Antimicrobial Agents and Chemotherapy ·Inna Radzishevsky,Shahar Rotem,Fadia Zaknoon,Leonid Gaidukov,Arie Dagan,Amram Mor	85
14	Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymesbreakdown → 2004 ·Nature Structural & Molecular Biology ·Michal Harel,Amir Aharoni,Leonid Gaidukov,Boris Brumshtein,Olga Khersonsky,Ran Meged,Hay Dvir,Raimond B. G. Ravelli,Andrew A. McCarthy,Lilly Toker,Israel Silman,Joel L. Sussman,Dan S. Tawfik	501
15	The 'evolvability' of promiscuous protein functionsbreakdown → 2004 ·Nature Genetics ·Amir Aharoni,Leonid Gaidukov,Olga Khersonsky,(unknown),Cintia Roodveldt,Dan S. Tawfik	660
16	Analysis of Membrane-Binding Properties of Dermaseptin Analogues: Relationships between Binding and Cytotoxicity 2003 ·Biochemistry ·Leonid Gaidukov,Alexander Fish,Amram Mor	56
17	Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization 2003 ·Proceedings of the National Academy of Sciences ·Amir Aharoni,Leonid Gaidukov,(unknown),Lilly Toker,Israel Silman,Dan S. Tawfik	234
18	Direct Interaction of Dermaseptin S4 Aminoheptanoyl Derivative with Intraerythrocytic Malaria Parasite Leading to Increased Specific Antiparasitic Activity in Culture 2002 ·Journal of Biological Chemistry ·(unknown),Arie Dagan,Leonid Gaidukov,Hagai Ginsburg,Amram Mor	66
19	Structural Requirements for Potent Versus Selective Cytotoxicity for Antimicrobial Dermaseptin S4 Derivatives 2002 ·Journal of Biological Chemistry ·I. M. Kustanovich,Deborah E. Shalev,(unknown),Leonid Gaidukov,Amram Mor	140
20	Antimalarial Activities of Dermaseptin S4 Derivatives 2000 ·Antimicrobial Agents and Chemotherapy ·Miriam Krugliak,Rina Feder,(unknown),Leonid Gaidukov,Arie Dagan,Hagai Ginsburg,Amram Mor	99

About Leonid Gaidukov

Leonid Gaidukov is a scholar working on Clinical Biochemistry, Microbiology and Biochemistry, having authored 24 papers that have together received 3.1k indexed citations. Recurring topics across this work include Paraoxonase enzyme and polymorphisms (10 papers), Antimicrobial Peptides and Activities (7 papers) and Biochemical and Structural Characterization (5 papers). The work is most often cited by research in Clinical Biochemistry (1.1k citations), Microbiology (574 citations) and Biochemistry (452 citations). Leonid Gaidukov has collaborated with scholars based in Israel, United States and Hong Kong. Frequent co-authors include Dan S. Tawfik, Amir Aharoni, Olga Khersonsky, Amram Mor, Cintia Roodveldt, Israel Silman, Lilly Toker, Mira Rosenblat, Michael Aviram and Arie Dagan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact